Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Olanzapine 2.5mg Tab 100 by Apotex Corp Gen Zyprexa UD

RX232145  232145  NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2  360505311002  360505-311002  MPN 311000RX232145  232145  NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2  360505311002  360505-311002  MPN 311000This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).RX232145  232145  NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2  360505311002  360505-311002  MPN 311000RX232145  232145  NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2  360505311002  360505-311002  MPN 311000

Olanzapine 2.5mg Tab 100 by Apotex Corp Gen Zyprexa UD

$56.42$14.99

RX232145 232145 NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2 360505311002 360505-311002 MPN 311000 Only Physician,Pharmacy or Licensed Facility can order this Rx Item No.Rx232145 232145 Olanzapine 2.5mg Tab 100 by Apotex Corp Item No.3232145 NDC No.60505311000 UPC No.360505311002 Other Name Zyprexa, Olanzapine Therapeutic Class Atypical Antipsychotics Item Class Non Controlled Rx. Case Qnty: 16 Atypical Antipsychotics Info Atypical Antipsychotic [E

Have a question?

Clinical Information
Gen. Code and Des.
29077 olanzapine ORAL TABLET 2.5 MG
GCN and Des.
15084 olanzapine ORAL TABLET 2.5 MG
Strength
2.5MG
Dose Form
TABLET
Product Category
RX Pharmaceuticals
Fine Line Class
850085008510 All Rx Products
DEA Class
NC
OMP Family

AHFS Class
28160804 ATYPICAL ANTIPSYCHOTICS
28280000 ANTIMANIC AGENTS
Active Ingredients
6204 olanzapine 132539061
Inactive Ingredients
2432 lactose 64044515




ZYPREXA - olanzapine tablet
ZYPREXA ZYDIS - olanzapine tablet, orally disintegrating
ZYPREXA INTRAMUSCULAR - olanzapine injection, powder, for solution
Eli Lilly and Company


WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS


Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. ZYPREXA (olanzapine) is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions (5.1, 5.13) and Patient Counseling Information


When using ZYPREXA and fluoxetine in combination, also refer to the Boxed Warning section of the package insert for Symbyax.


INDICATIONS AND USAGE


1.1 Schizophrenia
Oral ZYPREXA is indicated for the treatment of schizophrenia. Efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. In adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial [see Clinical Studies (14.1)].


When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. Clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see Warnings and Precautions (5.5)].


1.2 Bipolar I Disorder (Manic or Mixed Episodes)
Monotherapy - Oral ZYPREXA is indicated for the acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. Efficacy was established in three clinical trials in adult patients with manic or mixed episodes of bipolar I disorder: two 3- to 4-week trials and one monotherapy maintenance trial. In adolescent patients with manic or mixed episodes associated with bipolar I disorder (ages 13-17), efficacy was established in one 3-week trial [see Clinical Studies (14.2)].


When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. Clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see Warnings and Precautions (5.5)].


Adjunctive Therapy to Lithium or Valproate - Oral ZYPREXA is indicated for the treatment of manic or mixed episodes associated with bipolar I disorder as an adjunct to lithium or valproate. Efficacy was established in two 6-week clinical trials in adults. The effectiveness of adjunctive therapy for longer-term use has not been systematically evaluated in controlled trials [see Clinical Studies (14.2)].

RX232145  232145  NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2  360505311002  360505-311002  MPN 311000
Olanzapine 2.5mg Tab 100 by Apotex Corp
RX232145 232145 NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2 360505311002 360505-311002 MPN 311000

RX232145  232145  NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2  360505311002  360505-311002  MPN 311000
OLANZAPINE ORAL TABLET
RX232145 232145 NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2 360505311002 360505-311002 MPN 311000

This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).
Click above for Zyprexa !
This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).

RX232145  232145  NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2  360505311002  360505-311002  MPN 311000
Apotex Corp
RX232145 232145 NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2 360505311002 360505-311002 MPN 311000

RX232145  232145  NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2  360505311002  360505-311002  MPN 311000
OLANZAPINE ORAL TABLET
RX232145 232145 NDC No.60505-3110-00 60505-3110-0 6050531100 60505-3110-0 UPC/GTIN No.3-60505-31100-2 360505311002 360505-311002 MPN 311000